The Latest Breaking News from FDA

Male contraceptives are getting closer to market amid a tumultuous time for birth control and drug approvals.

FDA rejected Applied Therapeutics' Govorestat for galactosemia, citing NDA deficiencies. The company plans discussions for resubmission or appeal.

Tesla has introduced a major enhancement to its humanoid robot, Optimus, featuring new hands.

As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector.

Supreme Court to review FDA's ban on sweet e-cigarette flavors to address youth vaping epidemic.

Vaping is coming before the Supreme Court next week as federal regulators ask the high court to uphold its block on sweet, flavored products following a spike in youth e-cigarette use

People are mixing protein shakes and Diet Coke—and loving it.

Amid ongoing uncertainties surrounding the economy and global power dynamics, market volatility continues to dominate. In such times, investing in fundamentally sound blue-chip stocks, Johnson & Johnson (JNJ), American Express (AXP), and AT&T (T), could offer investors a stable foundation, serving as a buffer against market fluctuations and uncertainty. Read…

President-elect Trump's nominees for federal health agencies aim to reshape health oversight in alignment with Robert F. Kennedy Jr.'s health agenda.

"The FDA issued three alerts throughout 2024, warning consumers about lead in certain brands of cinnamon products"

Donald Trump's health team picks includes outspoken critics of the medical establishment and COVID-19 health measures